BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2022 9:29:39 AM | Browse: 468 | Download: 995
 |
Received |
|
2021-12-13 10:46 |
|
Peer-Review Started |
|
2021-12-13 10:47 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-03-13 22:46 |
|
Revised |
|
2022-03-15 04:24 |
|
Second Decision |
|
2022-04-26 02:16 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-04-26 22:06 |
|
Articles in Press |
|
2022-04-26 22:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-04-24 23:09 |
|
Typeset the Manuscript |
|
2022-05-23 06:35 |
|
Publish the Manuscript Online |
|
2022-05-26 09:29 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Inhibition of glutathione metabolism can limit the development of pancreatic cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Pei-Yuan Cai, Mei-Lin Ma, Yang-Fen Zhang, Zi-Xuan Zhou, Yan Wang, Lian-Ping He and Wei Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei Wang, MD, Attending Doctor, Department of Interventional Oncology, Municipal Hospital Affiliated to Taizhou University, No. 381-1 Zhongshan East Road, Jiaojiang District, Taizhou 318000, Zhejiang Province, China. westernfox000@163.com |
| Key Words |
Cancer stem cells; Chemoresistance; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Redox |
| Core Tip |
To reduce side effects, pharmacological inhibitors of glutathione synthesis and circulation, such as buthionine-sulfoximine and 6-aminonicotinamide, can be assessed by in vivo models of pancreatic cancer. Evaluating the impact of different organs on metabolic processes and the invasiveness of cancer stem cells may provide new avenues for therapeutics targeting tumor metabolism. |
| Publish Date |
2022-05-26 09:29 |
| Citation |
Cai PY, Ma ML, Zhang YF, Zhou ZX, Wang Y, He LP, Wang W. Inhibition of glutathione metabolism can limit the development of pancreatic cancer. World J Stem Cells 2022; 14(5): 362-364 |
| URL |
https://www.wjgnet.com/1948-0210/full/v14/i5/362.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v14.i5.362 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
